Key Insights

Highlights

Success Rate

85% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

2.0%

2 terminated out of 100 trials

Success Rate

84.6%

-1.9% vs benchmark

Late-Stage Pipeline

5%

5 trials in Phase 3/4

Results Transparency

73%

8 of 11 completed with results

Key Signals

8 with results85% success

Data Visualizations

Phase Distribution

76Total
Not Applicable (44)
Early P 1 (1)
P 1 (9)
P 2 (17)
P 3 (4)
P 4 (1)

Trial Status

Recruiting52
Not Yet Recruiting14
Active Not Recruiting13
Completed11
Enrolling By Invitation5
Suspended2

Trial Success Rate

84.6%

Benchmark: 86.6%

Based on 11 completed trials

Clinical Trials (100)

Showing 20 of 20 trials
NCT06827054Phase 2Not Yet RecruitingPrimary

Psilocybin With Psychotherapy for Improving Chronic Pain in Cancer Patients Requiring Opioids

NCT07535008Not ApplicableRecruiting

Dental Cleaning to Prevent Chronic Graft-Versus-Host Disease

NCT07126496Not ApplicableRecruitingPrimary

A Virtual Community Health Educator for Increasing Clinical Trial Referrals Among Cancer Patients and Their Caregivers

NCT06817889Phase 2RecruitingPrimary

Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals

NCT06304168RecruitingPrimary

Validation of DNA Methylation Markers for Universal and Site-specific Guided Cancer Detection, VANGUARD Study

NCT06353191RecruitingPrimary

Biomarkers to Predict Cancer Therapy-related Cardiotoxicity

NCT06880861RecruitingPrimary

Investigating Memory and Physical Activity After Cancer Treatment in Survivors of Adolescent and Young Adult Cancers

NCT04387656Active Not Recruiting

NCI COVID-19 in Cancer Patients, NCCAPS Study

NCT04320888Phase 2Active Not RecruitingPrimary

Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial

NCT07336238Phase 2Active Not Recruiting

Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies

NCT05691491Phase 1Recruiting

Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness

NCT07737314Not ApplicableNot Yet RecruitingPrimary

Tele-HOPE: A Telehealth Pharmacist Opioid Patient Education Pilot Study

NCT07285044Phase 2Recruiting

The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas

NCT06565260Not ApplicableRecruitingPrimary

Community-Based Exercise and Nutrition Training and Education Program for Cancer Survivors

NCT07733141Not ApplicableNot Yet Recruiting

Mindfulness Intervention to Reduce Patient Reported Symptoms in Patients With Chronic Graft-Versus-Host Disease

NCT06569316Not ApplicableRecruitingPrimary

Genetic Testing for the Prevention of Cancer in American Indian Communities (JUNIPER Trial)

NCT07020533Phase 1Recruiting

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

NCT07729384Not ApplicableNot Yet Recruiting

A Study of Strengthening Teen Brain Resilience Using Music During Cancer Treatment

NCT03223753Phase 3Completed

Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer

NCT06013423Phase 2Recruiting

Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases

Scroll to load more

Research Network

Activity Timeline